Squarepoint’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$541K Buy
107,360
+53,662
+100% +$270K ﹤0.01% 1863
2025
Q1
$348K Sell
53,698
-160,565
-75% -$1.04M ﹤0.01% 2113
2024
Q4
$1.57M Buy
214,263
+110,563
+107% +$812K ﹤0.01% 1282
2024
Q3
$777K Buy
103,700
+50,290
+94% +$377K ﹤0.01% 1548
2024
Q2
$475K Buy
+53,410
New +$475K ﹤0.01% 1750
2024
Q1
Sell
-221,855
Closed -$2.23M 2970
2023
Q4
$2.23M Buy
221,855
+49,214
+29% +$495K ﹤0.01% 974
2023
Q3
$1.62M Buy
+172,641
New +$1.62M ﹤0.01% 1071
2022
Q3
Sell
-70,630
Closed -$1.8M 2553
2022
Q2
$1.8M Sell
70,630
-48,578
-41% -$1.24M 0.01% 802
2022
Q1
$3.07M Buy
119,208
+95,737
+408% +$2.46M 0.01% 632
2021
Q4
$983K Buy
+23,471
New +$983K ﹤0.01% 1231
2021
Q2
Sell
-16,178
Closed -$829K 3064
2021
Q1
$829K Buy
+16,178
New +$829K ﹤0.01% 1213
2020
Q1
Sell
-13,234
Closed -$166K 2483
2019
Q4
$166K Buy
+13,234
New +$166K ﹤0.01% 2171